NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P102. A total of 21 filers reported holding NOVABAY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $29,000 | -54.7% | 103,100 | 0.0% | 0.00% | – |
| Q2 2015 | $64,000 | -1.5% | 103,100 | 0.0% | 0.00% | – |
| Q1 2015 | $65,000 | 0.0% | 103,100 | 0.0% | 0.00% | – |
| Q4 2014 | $65,000 | -25.3% | 103,100 | 0.0% | 0.00% | – |
| Q3 2014 | $87,000 | +7.4% | 103,100 | 0.0% | 0.00% | – |
| Q2 2014 | $81,000 | -27.0% | 103,100 | 0.0% | 0.00% | – |
| Q1 2014 | $111,000 | -14.0% | 103,100 | 0.0% | 0.00% | – |
| Q4 2013 | $129,000 | -26.7% | 103,100 | 0.0% | 0.00% | – |
| Q3 2013 | $176,000 | +23.9% | 103,100 | 0.0% | 0.00% | – |
| Q2 2013 | $142,000 | – | 103,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 1,000,000 | $630,000 | 0.56% |
| Orbitronix, LP | 309,800 | $214,000 | 0.12% |
| GARRISON BRADFORD & ASSOCIATES INC | 142,000 | $98,000 | 0.09% |
| WEDBUSH SECURITIES INC | 297,076 | $205,000 | 0.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 34,679 | $29,000 | 0.01% |
| Polar Asset Management Partners Inc. | 300,000 | $202,000 | 0.01% |
| GLENMEDE TRUST CO NA | 300,000 | $207,000 | 0.00% |
| RONALD BLUE & CO LLC | 32,000 | $22,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 59,623 | $41,000 | 0.00% |
| MORGAN STANLEY | 2,500 | $2,000 | 0.00% |